Cargando…
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study
Novel druggable targets are warranted for inflammatory bowel disease (IBD) treatment. We aimed to identify novel circulating proteins with causal associations with the risk of IBDs and provide potential therapeutic targets for IBD treatment. We performed a two‐sample Mendelian randomization (MR) stu...
Autores principales: | Mi, Jiarui, Wu, Xia, Bai, Xiaoyin, Yang, Yang, Yang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926074/ https://www.ncbi.nlm.nih.gov/pubmed/36333983 http://dx.doi.org/10.1111/cts.13442 |
Ejemplares similares
-
The Effects of Fatty Acids on Inflammatory Bowel Disease: A Two-Sample Mendelian Randomization Study
por: He, Jian, et al.
Publicado: (2022) -
Inflammatory bowel disease and cardiovascular disease: A two-sample Mendelian randomization analysis
por: Wu, Kaiwen, et al.
Publicado: (2022) -
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis
por: Cheng, Wen, et al.
Publicado: (2023) -
Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study
por: Min, Yu, et al.
Publicado: (2023) -
Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis
por: Dai, Zhujiang, et al.
Publicado: (2023)